News tagged ‘ImmuneSystem’ clear
- The use of monoclonal antibodies to activate an immune-system response
to abnormal cells resulted in a significant increase in survival time in
patients with metastatic melanoma, report Dana-Farber researchers.
Tags: ImmuneSystem, Melanoma, TranslationalResearch
- Dana-Farber researchers received the grant from the Defense Advanced
Research Projects Agency and the Army Research Office to develop a
treatment against known, unknown, naturally occurring, or engineered
Tags: Grants, ImmuneSystem
- Dana-Farber Cancer Institute scientists identify cells in mice that
prevent the immune system from attacking the animals' own cells,
protecting them from autoimmune diseases.
- Researchers reported promising preliminary outcomes for the first four children enrolled in a U.S. gene therapy trial for Wiskott-Aldrich syndrome (WAS), a life-threatening genetic blood and immune disorder, at the 57th annual meeting of the American Society of Hematology. All four boys have improved between nine and 24 months following treatment.
- Dana-Farber/Boston Children's researchers reported promising outcomes data for the first group of boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a fatal genetic immunodeficiency also known as "bubble boy" disease, who were treated in an international clinical study of a new form of gene therapy.
Tags: ChildhoodCancer, ImmuneSystem, Genetics, Leukemia
- The immune system's ability to police itself may offer a new method of
arresting the cells responsible for autoimmune diseases such as multiple
sclerosis and for the rejection of transplanted organs and tissues,
scientists at Dana-Farber report in a study in the May issue of the
- In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients.
Tags: BasicResearch, GraftVersusHost, ImmuneSystem
- Dana-Farber scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model. They say it holds promise for improved treatment of arthritis and other autoimmune disorders in people.
- A clinical trial for advanced melanoma caused growths to recede or stabilize in half of the participants by blocking a protein interaction that prevents T cells from attacking cancerous cells, reports lead author Stephen Hodi, MD.
Tags: ImmuneSystem, Melanoma